FDA Guidance on Conduct of Clinical Trials during the COVID-19 Pandemic
The FDA issued a guidance on how the COVID-19 Pandemic may affect the conduct of clinical trials. Click below for some key messages from the guidance along with some interpretations and recommendations based on the assessments by Cytel's consultants and statisticians. Click here to access the guidance.
Complete the form to contact a consultant if you have any questions.